These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38438)

  • 1. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
    Schümichen C; Walden J; Hoffmann G
    Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of stannous chelates administered with 99mTc-labeled chelates.
    Dewanjee MK; Wahner HW
    Radiology; 1979 Sep; 132(3):711-716. PubMed ID: 224413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and in-vivo-distribution of different 99mTc-Sn-pyrophosphate complexes.
    Schümichen C; Roth KH; Hoffmann G
    Nucl Med (Stuttg); 1975 Dec; 14(4):323-9. PubMed ID: 2905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
    Schümichen C; Mackenbrock B; Hoffmann G
    Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
    Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
    Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
    Kaye M; Silverton S; Rosenthall L
    J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 13. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium.
    Dewanjee MK; Kahn PC
    J Nucl Med; 1976 Jul; 17(7):639-46. PubMed ID: 178842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
    Büll U; von Lieven H; Leisner B
    Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.
    Guillemart A; Besnard JC; Le Pape A; Galy G; Fetissoff F
    J Nucl Med; 1978 Aug; 19(8):895-9. PubMed ID: 210266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.